-+ 0.00%
-+ 0.00%
-+ 0.00%

Processa Pharmaceuticals Reports Promising Phase 2 Data for NGC-Cap in Metastatic Breast Cancer

Reuters·12/17/2025 13:01:31

Please log in to view news